Latest News & Articles
Browse all our latest news articles and stories
FAQ: Nutriband Inc. Presentation at Noble Capital Markets Emerging Growth Virtual Conference
Nutriband Inc. (NASDAQ: NTRB) announced CEO Gareth Sheridan will present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference, …
Energy Fuels Inc. Achieves Record Uranium Production and Advances Key Projects: FAQ
FAQ: ECGI Holdings Inc. Invests in AI Startup TrueToForm Through Uplist Ventures
FAQ on Trillion Energy International Inc.'s Debt Settlement via Share Issuance
FAQ: Mullen Automotive's Increased Ownership in Bollinger Motors and Resolution of Receivership
FAQ: Google Study on Quantum Computers and Bitcoin Security
A Google-linked study suggests fewer quantum computers than previously thought could break Bitcoin's encryption, highlighting the urgent need for the …
FAQ: Korean Researchers' AI Model for Predicting Cancer Patients' Response to Immunotherapy
A South Korean research team has developed an AI model to predict cancer patients' response to immunotherapy, aiming to enhance treatment precision …
FAQ: Knightscope, Inc. Secures Over $1 Million in Contracts for AI-Powered Security Solutions
FAQ: Ucore Rare Metals Inc. Secures $18.4M DoD Award for RapidSX(TM) System
FAQ: Foremost Clean Energy Ltd. Appoints Cameron MacKay as VP of Exploration to Drive Uranium Strategy
FAQ on Sekur Private Data Ltd.'s Strategic Advisory Board Appointment for Global Growth
Sekur Private Data Ltd. has formed a Strategic Advisory Board with three high-profile members to drive global expansion, strategic partnerships, and …
FAQ: Nicola Mining Inc.'s Mill Restart and Multi-Metal Growth Strategy
FAQ: Datavault AI Inc.'s Participation in Maxim’s 2025 Virtual Tech Conference
FAQ: The Rise of Gold as a Hedge and the Emergence of ESGold Corp.
FAQ on Lahontan Gold Corp.'s 2025 Drilling Program at Santa Fe Mine
FAQ on Nutriband Inc.'s Record Q1 Revenue and AVERSA Fentanyl Development
FAQ on Telomir Pharmaceuticals' Participation in BIO 2025 and IND Preparation for Telomir-1
Telomir Pharmaceuticals is set to participate in BIO 2025 to explore partnerships for its lead candidate, Telomir-1, aimed at reversing aging …